Plant Metabolites as SARS-CoV-2 Inhibitors Candidates: In Silico and In Vitro Studies
Since it acquired pandemic status, SARS-CoV-2 has been causing all kinds of damage all over the world. More than 6.3 million people have died, and many cases of sequelae are in survivors. Currently, the only products available to most of the world's population to fight the pandemic are vaccines...
Saved in:
Main Authors: | Alberto Jorge Oliveira Lopes (Author), Gustavo Pereira Calado (Author), Yuri Nascimento Fróes (Author), Sandra Alves de Araújo (Author), Lucas Martins França (Author), Antonio Marcus de Andrade Paes (Author), Sebastião Vieira de Morais (Author), Cláudia Quintino da Rocha (Author), Cleydlenne Costa Vasconcelos (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An in Silico Approach to Find the Molecular Targets and Potential Candidates for SARS-CoV-2
by: Amir Zarrinhaghighi, et al.
Published: (2020) -
Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors
by: Patricia Rijo, et al.
Published: (2022) -
In silico phytochemicals analysis as inhibitors of the SARS-COV-2 main protease
by: Ekaterina Serikova, et al.
Published: (2022) -
Anti-Inflammatory and Antioxidant Activity of Pollen Extract Collected by <i>Scaptotrigona affinis postica</i>: in silico, in vitro, and in vivo Studies
by: Alberto Jorge Oliveira Lopes, et al.
Published: (2020) -
In silico study of the toxicity of hyperforin and its metabolites
by: Ivelin Iliev, et al.
Published: (2023)